The first and only materials combining: Electrical exogenous stimulus enhancing endogenous wound healing processes Best antimicrobial efficacy Highest safety profile Many applications and huge market potential The unique electrical properties of our compound play two major roles in wound care: 1. Facilitate cellular activities fundamental to wound healing. 2. Actively attracts and adheres pathogens, bringing them into proximity with the pathogen-killing metal oxide particles that are part of our compounds (contact us for full description). The only and first true solution for chronic (hard-to-heal) wound treatment. Hard to heal wounds accounts for 56% of the wound care market while acute wounds accounts for market share 44%. The global chronic wound care market was valued at ~$15 billion in 2025 and is projected to reach $25 billion by 2032, driven by rising diabetes, obesity, vascular diseases, and an aging population. Our primary market is chronic wounds. Our proprietary compounds can be used in other various $USB markets: Catheters and implants, for example, to prevent UTI Burns treatment Face masks Hygiene products – pads, diapers Cosmetic Odor preventive agent in antiperspirants Hygienic clothes, bedsheets Antiseptic planes Non-medical applications, such as food storage We conducted multiple tests internally as well as with industry players in accordance with standard study protocols, demonstrating our compounds’ superiority in safety and efficacy compared with competing current chronic wound-treating solutions. We can share these study reports with you. Deep-tech - strong IP Medical device class II 510(k) refulatory path Competitive price